0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Oxcarbazepine Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-17X7133
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Oxcarbazepine Drug Market Insights Forecast to 2028
BUY CHAPTERS

Oxcarbazepine Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-17X7133
Report
October 2024
Pages:129
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Oxcarbazepine Drug - Market Size

The global market for Oxcarbazepine Drug was estimated to be worth US$ 432 million in 2023 and is forecast to a readjusted size of US$ 626.9 million by 2030 with a CAGR of 5.8% during the forecast period 2024-2030

Oxcarbazepine Drug - Market

Oxcarbazepine Drug - Market

Oxcarbazepine is an anticonvulsant medication primarily used in the treatment of epilepsy. It may also be used as add-on therapy for bipolar disorder in people that have failed or are unable to tolerate other treatments.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oxcarbazepine Drug, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Oxcarbazepine Drug by region & country, by Type, and by Application.
The Oxcarbazepine Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oxcarbazepine Drug.
Market Segmentation

Scope of Oxcarbazepine Drug - Market Report

Report Metric Details
Report Name Oxcarbazepine Drug - Market
Forecasted market size in 2030 US$ 626.9 million
CAGR 5.8%
Forecasted years 2024 - 2030
Segment by Type:
  • Tablet
  • Oral Suspension
Segment by Application
  • Adult
  • Pediatric
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis, Supernus Pharmaceuticals, Apotex, West-Ward Pharmaceuticals, Taro Pharmaceuticals, Glenmark Pharmaceuticals, ANI Pharmaceuticals, Breckenridge Pharmaceutical, Amneal Pharmaceuticals, Teva, SihuanPharm, Humanwell
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Oxcarbazepine Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Oxcarbazepine Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Oxcarbazepine Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Oxcarbazepine Drug - Market size in 2030?

Ans: The Oxcarbazepine Drug - Market size in 2030 will be US$ 626.9 million.

Who are the main players in the Oxcarbazepine Drug - Market report?

Ans: The main players in the Oxcarbazepine Drug - Market are Novartis, Supernus Pharmaceuticals, Apotex, West-Ward Pharmaceuticals, Taro Pharmaceuticals, Glenmark Pharmaceuticals, ANI Pharmaceuticals, Breckenridge Pharmaceutical, Amneal Pharmaceuticals, Teva, SihuanPharm, Humanwell

What are the Application segmentation covered in the Oxcarbazepine Drug - Market report?

Ans: The Applications covered in the Oxcarbazepine Drug - Market report are Adult, Pediatric

What are the Type segmentation covered in the Oxcarbazepine Drug - Market report?

Ans: The Types covered in the Oxcarbazepine Drug - Market report are Tablet, Oral Suspension

1 Market Overview
1.1 Oxcarbazepine Drug Product Introduction
1.2 Global Oxcarbazepine Drug Market Size Forecast
1.2.1 Global Oxcarbazepine Drug Sales Value (2019-2030)
1.2.2 Global Oxcarbazepine Drug Sales Volume (2019-2030)
1.2.3 Global Oxcarbazepine Drug Sales Price (2019-2030)
1.3 Oxcarbazepine Drug Market Trends & Drivers
1.3.1 Oxcarbazepine Drug Industry Trends
1.3.2 Oxcarbazepine Drug Market Drivers & Opportunity
1.3.3 Oxcarbazepine Drug Market Challenges
1.3.4 Oxcarbazepine Drug Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Oxcarbazepine Drug Players Revenue Ranking (2023)
2.2 Global Oxcarbazepine Drug Revenue by Company (2019-2024)
2.3 Global Oxcarbazepine Drug Players Sales Volume Ranking (2023)
2.4 Global Oxcarbazepine Drug Sales Volume by Company Players (2019-2024)
2.5 Global Oxcarbazepine Drug Average Price by Company (2019-2024)
2.6 Key Manufacturers Oxcarbazepine Drug Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Oxcarbazepine Drug Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Oxcarbazepine Drug
2.9 Oxcarbazepine Drug Market Competitive Analysis
2.9.1 Oxcarbazepine Drug Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Oxcarbazepine Drug Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oxcarbazepine Drug as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Tablet
3.1.2 Oral Suspension
3.2 Global Oxcarbazepine Drug Sales Value by Type
3.2.1 Global Oxcarbazepine Drug Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Oxcarbazepine Drug Sales Value, by Type (2019-2030)
3.2.3 Global Oxcarbazepine Drug Sales Value, by Type (%) (2019-2030)
3.3 Global Oxcarbazepine Drug Sales Volume by Type
3.3.1 Global Oxcarbazepine Drug Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Oxcarbazepine Drug Sales Volume, by Type (2019-2030)
3.3.3 Global Oxcarbazepine Drug Sales Volume, by Type (%) (2019-2030)
3.4 Global Oxcarbazepine Drug Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Adult
4.1.2 Pediatric
4.2 Global Oxcarbazepine Drug Sales Value by Application
4.2.1 Global Oxcarbazepine Drug Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Oxcarbazepine Drug Sales Value, by Application (2019-2030)
4.2.3 Global Oxcarbazepine Drug Sales Value, by Application (%) (2019-2030)
4.3 Global Oxcarbazepine Drug Sales Volume by Application
4.3.1 Global Oxcarbazepine Drug Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Oxcarbazepine Drug Sales Volume, by Application (2019-2030)
4.3.3 Global Oxcarbazepine Drug Sales Volume, by Application (%) (2019-2030)
4.4 Global Oxcarbazepine Drug Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Oxcarbazepine Drug Sales Value by Region
5.1.1 Global Oxcarbazepine Drug Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Oxcarbazepine Drug Sales Value by Region (2019-2024)
5.1.3 Global Oxcarbazepine Drug Sales Value by Region (2025-2030)
5.1.4 Global Oxcarbazepine Drug Sales Value by Region (%), (2019-2030)
5.2 Global Oxcarbazepine Drug Sales Volume by Region
5.2.1 Global Oxcarbazepine Drug Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Oxcarbazepine Drug Sales Volume by Region (2019-2024)
5.2.3 Global Oxcarbazepine Drug Sales Volume by Region (2025-2030)
5.2.4 Global Oxcarbazepine Drug Sales Volume by Region (%), (2019-2030)
5.3 Global Oxcarbazepine Drug Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Oxcarbazepine Drug Sales Value, 2019-2030
5.4.2 North America Oxcarbazepine Drug Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Oxcarbazepine Drug Sales Value, 2019-2030
5.5.2 Europe Oxcarbazepine Drug Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Oxcarbazepine Drug Sales Value, 2019-2030
5.6.2 Asia Pacific Oxcarbazepine Drug Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Oxcarbazepine Drug Sales Value, 2019-2030
5.7.2 South America Oxcarbazepine Drug Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Oxcarbazepine Drug Sales Value, 2019-2030
5.8.2 Middle East & Africa Oxcarbazepine Drug Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Oxcarbazepine Drug Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Oxcarbazepine Drug Sales Value
6.2.1 Key Countries/Regions Oxcarbazepine Drug Sales Value, 2019-2030
6.2.2 Key Countries/Regions Oxcarbazepine Drug Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Oxcarbazepine Drug Sales Value, 2019-2030
6.3.2 United States Oxcarbazepine Drug Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Oxcarbazepine Drug Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Oxcarbazepine Drug Sales Value, 2019-2030
6.4.2 Europe Oxcarbazepine Drug Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Oxcarbazepine Drug Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Oxcarbazepine Drug Sales Value, 2019-2030
6.5.2 China Oxcarbazepine Drug Sales Value by Type (%), 2023 VS 2030
6.5.3 China Oxcarbazepine Drug Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Oxcarbazepine Drug Sales Value, 2019-2030
6.6.2 Japan Oxcarbazepine Drug Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Oxcarbazepine Drug Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Oxcarbazepine Drug Sales Value, 2019-2030
6.7.2 South Korea Oxcarbazepine Drug Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Oxcarbazepine Drug Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Oxcarbazepine Drug Sales Value, 2019-2030
6.8.2 Southeast Asia Oxcarbazepine Drug Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Oxcarbazepine Drug Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Oxcarbazepine Drug Sales Value, 2019-2030
6.9.2 India Oxcarbazepine Drug Sales Value by Type (%), 2023 VS 2030
6.9.3 India Oxcarbazepine Drug Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Novartis
7.1.1 Novartis Company Information
7.1.2 Novartis Introduction and Business Overview
7.1.3 Novartis Oxcarbazepine Drug Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Novartis Oxcarbazepine Drug Product Offerings
7.1.5 Novartis Recent Development
7.2 Supernus Pharmaceuticals
7.2.1 Supernus Pharmaceuticals Company Information
7.2.2 Supernus Pharmaceuticals Introduction and Business Overview
7.2.3 Supernus Pharmaceuticals Oxcarbazepine Drug Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Supernus Pharmaceuticals Oxcarbazepine Drug Product Offerings
7.2.5 Supernus Pharmaceuticals Recent Development
7.3 Apotex
7.3.1 Apotex Company Information
7.3.2 Apotex Introduction and Business Overview
7.3.3 Apotex Oxcarbazepine Drug Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Apotex Oxcarbazepine Drug Product Offerings
7.3.5 Apotex Recent Development
7.4 West-Ward Pharmaceuticals
7.4.1 West-Ward Pharmaceuticals Company Information
7.4.2 West-Ward Pharmaceuticals Introduction and Business Overview
7.4.3 West-Ward Pharmaceuticals Oxcarbazepine Drug Sales, Revenue and Gross Margin (2019-2024)
7.4.4 West-Ward Pharmaceuticals Oxcarbazepine Drug Product Offerings
7.4.5 West-Ward Pharmaceuticals Recent Development
7.5 Taro Pharmaceuticals
7.5.1 Taro Pharmaceuticals Company Information
7.5.2 Taro Pharmaceuticals Introduction and Business Overview
7.5.3 Taro Pharmaceuticals Oxcarbazepine Drug Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Taro Pharmaceuticals Oxcarbazepine Drug Product Offerings
7.5.5 Taro Pharmaceuticals Recent Development
7.6 Glenmark Pharmaceuticals
7.6.1 Glenmark Pharmaceuticals Company Information
7.6.2 Glenmark Pharmaceuticals Introduction and Business Overview
7.6.3 Glenmark Pharmaceuticals Oxcarbazepine Drug Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Glenmark Pharmaceuticals Oxcarbazepine Drug Product Offerings
7.6.5 Glenmark Pharmaceuticals Recent Development
7.7 ANI Pharmaceuticals
7.7.1 ANI Pharmaceuticals Company Information
7.7.2 ANI Pharmaceuticals Introduction and Business Overview
7.7.3 ANI Pharmaceuticals Oxcarbazepine Drug Sales, Revenue and Gross Margin (2019-2024)
7.7.4 ANI Pharmaceuticals Oxcarbazepine Drug Product Offerings
7.7.5 ANI Pharmaceuticals Recent Development
7.8 Breckenridge Pharmaceutical
7.8.1 Breckenridge Pharmaceutical Company Information
7.8.2 Breckenridge Pharmaceutical Introduction and Business Overview
7.8.3 Breckenridge Pharmaceutical Oxcarbazepine Drug Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Breckenridge Pharmaceutical Oxcarbazepine Drug Product Offerings
7.8.5 Breckenridge Pharmaceutical Recent Development
7.9 Amneal Pharmaceuticals
7.9.1 Amneal Pharmaceuticals Company Information
7.9.2 Amneal Pharmaceuticals Introduction and Business Overview
7.9.3 Amneal Pharmaceuticals Oxcarbazepine Drug Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Amneal Pharmaceuticals Oxcarbazepine Drug Product Offerings
7.9.5 Amneal Pharmaceuticals Recent Development
7.10 Teva
7.10.1 Teva Company Information
7.10.2 Teva Introduction and Business Overview
7.10.3 Teva Oxcarbazepine Drug Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Teva Oxcarbazepine Drug Product Offerings
7.10.5 Teva Recent Development
7.11 SihuanPharm
7.11.1 SihuanPharm Company Information
7.11.2 SihuanPharm Introduction and Business Overview
7.11.3 SihuanPharm Oxcarbazepine Drug Sales, Revenue and Gross Margin (2019-2024)
7.11.4 SihuanPharm Oxcarbazepine Drug Product Offerings
7.11.5 SihuanPharm Recent Development
7.12 Humanwell
7.12.1 Humanwell Company Information
7.12.2 Humanwell Introduction and Business Overview
7.12.3 Humanwell Oxcarbazepine Drug Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Humanwell Oxcarbazepine Drug Product Offerings
7.12.5 Humanwell Recent Development
8 Industry Chain Analysis
8.1 Oxcarbazepine Drug Industrial Chain
8.2 Oxcarbazepine Drug Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Oxcarbazepine Drug Sales Model
8.5.2 Sales Channel
8.5.3 Oxcarbazepine Drug Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Oxcarbazepine Drug Market Trends
    Table 2. Oxcarbazepine Drug Market Drivers & Opportunity
    Table 3. Oxcarbazepine Drug Market Challenges
    Table 4. Oxcarbazepine Drug Market Restraints
    Table 5. Global Oxcarbazepine Drug Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Oxcarbazepine Drug Revenue Market Share by Company (2019-2024)
    Table 7. Global Oxcarbazepine Drug Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Oxcarbazepine Drug Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Oxcarbazepine Drug Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Oxcarbazepine Drug Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Oxcarbazepine Drug Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Oxcarbazepine Drug
    Table 13. Global Oxcarbazepine Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oxcarbazepine Drug as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Oxcarbazepine Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Oxcarbazepine Drug Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Oxcarbazepine Drug Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Oxcarbazepine Drug Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Oxcarbazepine Drug Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Oxcarbazepine Drug Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Oxcarbazepine Drug Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Oxcarbazepine Drug Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Oxcarbazepine Drug Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Oxcarbazepine Drug Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Oxcarbazepine Drug Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Oxcarbazepine Drug Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Oxcarbazepine Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Oxcarbazepine Drug Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Oxcarbazepine Drug Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Oxcarbazepine Drug Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Oxcarbazepine Drug Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Oxcarbazepine Drug Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Oxcarbazepine Drug Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Oxcarbazepine Drug Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Oxcarbazepine Drug Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Oxcarbazepine Drug Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Oxcarbazepine Drug Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Oxcarbazepine Drug Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Oxcarbazepine Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Oxcarbazepine Drug Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Oxcarbazepine Drug Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Oxcarbazepine Drug Sales Value by Region (2019-2024) & (%)
    Table 44. Global Oxcarbazepine Drug Sales Value by Region (2025-2030) & (%)
    Table 45. Global Oxcarbazepine Drug Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Oxcarbazepine Drug Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Oxcarbazepine Drug Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Oxcarbazepine Drug Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Oxcarbazepine Drug Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Oxcarbazepine Drug Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Oxcarbazepine Drug Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Oxcarbazepine Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Oxcarbazepine Drug Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Oxcarbazepine Drug Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Oxcarbazepine Drug Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Oxcarbazepine Drug Sales Volume, (2025-2030) & (K Units)
    Table 57. Novartis Company Information
    Table 58. Novartis Introduction and Business Overview
    Table 59. Novartis Oxcarbazepine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. Novartis Oxcarbazepine Drug Product Offerings
    Table 61. Novartis Recent Development
    Table 62. Supernus Pharmaceuticals Company Information
    Table 63. Supernus Pharmaceuticals Introduction and Business Overview
    Table 64. Supernus Pharmaceuticals Oxcarbazepine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. Supernus Pharmaceuticals Oxcarbazepine Drug Product Offerings
    Table 66. Supernus Pharmaceuticals Recent Development
    Table 67. Apotex Company Information
    Table 68. Apotex Introduction and Business Overview
    Table 69. Apotex Oxcarbazepine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. Apotex Oxcarbazepine Drug Product Offerings
    Table 71. Apotex Recent Development
    Table 72. West-Ward Pharmaceuticals Company Information
    Table 73. West-Ward Pharmaceuticals Introduction and Business Overview
    Table 74. West-Ward Pharmaceuticals Oxcarbazepine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. West-Ward Pharmaceuticals Oxcarbazepine Drug Product Offerings
    Table 76. West-Ward Pharmaceuticals Recent Development
    Table 77. Taro Pharmaceuticals Company Information
    Table 78. Taro Pharmaceuticals Introduction and Business Overview
    Table 79. Taro Pharmaceuticals Oxcarbazepine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. Taro Pharmaceuticals Oxcarbazepine Drug Product Offerings
    Table 81. Taro Pharmaceuticals Recent Development
    Table 82. Glenmark Pharmaceuticals Company Information
    Table 83. Glenmark Pharmaceuticals Introduction and Business Overview
    Table 84. Glenmark Pharmaceuticals Oxcarbazepine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. Glenmark Pharmaceuticals Oxcarbazepine Drug Product Offerings
    Table 86. Glenmark Pharmaceuticals Recent Development
    Table 87. ANI Pharmaceuticals Company Information
    Table 88. ANI Pharmaceuticals Introduction and Business Overview
    Table 89. ANI Pharmaceuticals Oxcarbazepine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 90. ANI Pharmaceuticals Oxcarbazepine Drug Product Offerings
    Table 91. ANI Pharmaceuticals Recent Development
    Table 92. Breckenridge Pharmaceutical Company Information
    Table 93. Breckenridge Pharmaceutical Introduction and Business Overview
    Table 94. Breckenridge Pharmaceutical Oxcarbazepine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 95. Breckenridge Pharmaceutical Oxcarbazepine Drug Product Offerings
    Table 96. Breckenridge Pharmaceutical Recent Development
    Table 97. Amneal Pharmaceuticals Company Information
    Table 98. Amneal Pharmaceuticals Introduction and Business Overview
    Table 99. Amneal Pharmaceuticals Oxcarbazepine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 100. Amneal Pharmaceuticals Oxcarbazepine Drug Product Offerings
    Table 101. Amneal Pharmaceuticals Recent Development
    Table 102. Teva Company Information
    Table 103. Teva Introduction and Business Overview
    Table 104. Teva Oxcarbazepine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 105. Teva Oxcarbazepine Drug Product Offerings
    Table 106. Teva Recent Development
    Table 107. SihuanPharm Company Information
    Table 108. SihuanPharm Introduction and Business Overview
    Table 109. SihuanPharm Oxcarbazepine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 110. SihuanPharm Oxcarbazepine Drug Product Offerings
    Table 111. SihuanPharm Recent Development
    Table 112. Humanwell Company Information
    Table 113. Humanwell Introduction and Business Overview
    Table 114. Humanwell Oxcarbazepine Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 115. Humanwell Oxcarbazepine Drug Product Offerings
    Table 116. Humanwell Recent Development
    Table 117. Key Raw Materials Lists
    Table 118. Raw Materials Key Suppliers Lists
    Table 119. Oxcarbazepine Drug Downstream Customers
    Table 120. Oxcarbazepine Drug Distributors List
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Oxcarbazepine Drug Product Picture
    Figure 2. Global Oxcarbazepine Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Oxcarbazepine Drug Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Oxcarbazepine Drug Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Oxcarbazepine Drug Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Oxcarbazepine Drug Report Years Considered
    Figure 7. Global Oxcarbazepine Drug Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Oxcarbazepine Drug Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Oxcarbazepine Drug Revenue in 2023
    Figure 10. Oxcarbazepine Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Tablet Picture
    Figure 12. Oral Suspension Picture
    Figure 13. Global Oxcarbazepine Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Oxcarbazepine Drug Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Oxcarbazepine Drug Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Oxcarbazepine Drug Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Oxcarbazepine Drug Price by Type (2019-2030) & (USD/Unit)
    Figure 18. Product Picture of Adult
    Figure 19. Product Picture of Pediatric
    Figure 20. Global Oxcarbazepine Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Oxcarbazepine Drug Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global Oxcarbazepine Drug Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 23. Global Oxcarbazepine Drug Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global Oxcarbazepine Drug Price by Application (2019-2030) & (USD/Unit)
    Figure 25. North America Oxcarbazepine Drug Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Oxcarbazepine Drug Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Oxcarbazepine Drug Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Oxcarbazepine Drug Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Oxcarbazepine Drug Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Oxcarbazepine Drug Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Oxcarbazepine Drug Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Oxcarbazepine Drug Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Oxcarbazepine Drug Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Oxcarbazepine Drug Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Oxcarbazepine Drug Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions Oxcarbazepine Drug Sales Volume (%), (2019-2030)
    Figure 37. United States Oxcarbazepine Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Oxcarbazepine Drug Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Oxcarbazepine Drug Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Oxcarbazepine Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Oxcarbazepine Drug Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Oxcarbazepine Drug Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Oxcarbazepine Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Oxcarbazepine Drug Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Oxcarbazepine Drug Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Oxcarbazepine Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Oxcarbazepine Drug Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Oxcarbazepine Drug Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Oxcarbazepine Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Oxcarbazepine Drug Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Oxcarbazepine Drug Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Oxcarbazepine Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Oxcarbazepine Drug Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Oxcarbazepine Drug Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Oxcarbazepine Drug Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Oxcarbazepine Drug Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Oxcarbazepine Drug Sales Value by Application (%), 2023 VS 2030
    Figure 58. Oxcarbazepine Drug Industrial Chain
    Figure 59. Oxcarbazepine Drug Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Naloxone - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-38P6846
Mon Oct 07 00:00:00 UTC 2024

Add to Cart

Triptorelin Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-18C7047
Mon Oct 07 00:00:00 UTC 2024

Add to Cart

Oxcarbazepine Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-17X7133
Mon Oct 07 00:00:00 UTC 2024

Add to Cart

Mirtazapine Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-18V7049
Mon Oct 07 00:00:00 UTC 2024

Add to Cart